Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Congress Newsletter 2022

Becoming a Fellow of the European Society of Anaesthesiology and Intensive Care (FESAIC)

As part of his time in office as society President, Prof Kai Zacharowski introduced the system of Fellowship of ESAIC (see interview text below). Becoming a Fellow of the European Society of Anaesthesiology and Intensive Care (FESAIC™) is a prestigious honour awarded to healthcare professionals who have made a significant contribution to anaesthesiology and intensive care.

“To be a FESAIC indicates and proves an exceptional level of service to the Society and patients – from congress and research to education and advocacy – that distinguish FESAIC from their peers,” Kai explains. “The FESAIC title is now recognised throughout the anaesthesiology and intensive care community as a symbol of excellence.”

“Being a FESAIC is not only a recognition of your contribution to anaesthesiology and intensive care, but it also means that you belong to a dedicated group of professionals that demonstrate integrity and excellence in the care of your patients.”

The two pathways by which one can apply for Fellowship are detailed on the FESAIC page of ESAIC.

Former Presidents Paolo Pelosi and Stefan De Hert were the first to be awarded FESAIC in 2021. Below, Kai tells us more about this project.

Q: Kai, are you able to tell us about some new Fellowships awarded in 2022?

A: Of course, with great pleasure. We have awarded 42 FESAICS this year, including all four of this year’s Honorary Members who received their awards in the opening ceremony. A further 30 were able to receive them at yesterday’s award ceremony. My warmest congratulations to all of them.

We have received plenty of applications around Europe and even from different continents. To ensure a very high standard of review we have established a review board. All applications will be first screened by the ESAIC Headquarters, where checks are made to ensure all the formal conditions are fulfilled. Hereafter, the ‘Review Board FESAIC’ is meeting and going through all applications piece by piece (through both pathways you can see in the link above). Hereafter, decisions are made. The pathway is a highly professional decision-making process.

Q: What made you introduce the Fellow system, and how is different from, for example, becoming an Honorary Member?

A: An Honorary Member is recognised due to the actions of the Society (this person has done a lot to bring ESAIC forward…). To become a FESAIC without (or as well as) being an Honorary Member is a more personal thing, this person has achieved great things in her/his professional life…

Q: We know that yours was the most unusual Presidency probably in the society’s history, due to the COVID Pandemic. But this global emergency also energised the anaesthesiology and intensive care communities. What are your highlights from your 2 years in charge?

A: The name change to ESAIC (it took me 8 years of preparation); this  FESAIC project is my baby!; and obtaining EU projects and research projects for ESAIC and to further evolve the Patient Blood Management Program (www.patientbloodmanagement.eu).

Q: We are likely to experience further waves of COVID-19 as autumn and winter approach. You have helped ESAIC obtain a lot of funding to address this global health concern. Tell us about these projects?

A: Firstly our ENVISION study received 6 million euros of funding, and this project has generated the data which now will be analysed and used to ‘train’ our systems so that artificial intelligence software will look for new treatments for COVID-19.

Our other COVend project was awarded 10 million Euros which was used to produce a new treatment (called FX06) to prevent or reduce the worsening of COVID infection. As the underlying pathological disease process of COVID-19 is characterized by a continuous progression of endothelial injury, FX06, a protective substance against endothelial damage, is expected to prevent the disease from progressing from a moderate to a severe stage. A multi-centre clinical trial (called IXION) will now assess the efficacy of this treatment.




Read More of our special newsletter covering our congress.